Johnson Eric O, Chen Li-Shiun, Breslau Naomi, Hatsukami Dorothy, Robbins Tania, Saccone Nancy L, Grucza Richard A, Bierut Laura J
Behavioral Health Epidemiology Program, Research Triangle Institute International, 3040 Cornwallis Road, Research Triangle Park, NC 27709-2194, USA.
Addiction. 2010 Nov;105(11):2014-22. doi: 10.1111/j.1360-0443.2010.03074.x. Epub 2010 Sep 15.
Peer smoking provides a socially reinforcing context of friends' encouragement and approval that contributes to smoking behavior. Twin studies show correlations and interactions between peer substance use and genetic liability for substance use. However, none examined specific genes. Here we test the hypothesis that the nicotinic receptor genes CHRNA5 (rs16969968), CHRNA3 (rs578776), CHRNB3 (rs13277254) and CHRND (rs12466358) modify the risk for nicotine dependence associated with peer smoking.
Cases of current nicotine dependence [Fagerström Test for Nicotine Dependence (FTND)≥ 4] and smoking-exposed (smoked 100+ cigarettes life-time), but non-dependent controls (life-time FTND= 0) came from the Collaborative Genetic Study of Nicotine Dependence (n=2038). Peer smoking was assessed retrospectively for grades 9-12.
Peer smoking and the four single nucleotide polymorphisms (SNPs) were associated with nicotine dependence. A statistically significant interaction was found between peer smoking and rs16969968 (P=0.0077). Overall risk of nicotine dependence was highest for the rs16969968 AA genotype. However, variance in nicotine dependence attributable to peer smoking was substantially lower among those with the AA genotype at rs16969968 than the lower-risk genotypes: AA=2.5%, GA/AG=11.2%, GG=14.2%; P≤ 0.004.
Peer smoking had a substantially lower effect on nicotine dependence among those with the high-risk AA genotype at the functional SNP rs16969968 (CHRNA5) than among those with lower-risk genotypes. Such results highlight the possibility that given drug exposure those with specific genetic risks may be less affected by social contexts and intervention strategies focused upon social factors could have less influence on those at highest genetic risk.
同伴吸烟提供了一种朋友鼓励和认可的社会强化环境,这会导致吸烟行为。双胞胎研究表明同伴物质使用与物质使用的遗传易感性之间存在相关性和相互作用。然而,没有研究考察特定基因。在此,我们检验以下假设:烟碱受体基因CHRNA5(rs16969968)、CHRNA3(rs578776)、CHRNB3(rs13277254)和CHRND(rs12466358)会改变与同伴吸烟相关的尼古丁依赖风险。
当前尼古丁依赖病例[尼古丁依赖的法格斯特罗姆测试(FTND)≥4]以及有吸烟经历(终生吸烟100支以上)但无依赖的对照者(终生FTND = 0)来自尼古丁依赖协作基因研究(n = 2038)。对9至12年级的同伴吸烟情况进行回顾性评估。
同伴吸烟和四个单核苷酸多态性(SNP)与尼古丁依赖相关。发现同伴吸烟与rs16969968之间存在统计学上显著的相互作用(P = 0.0077)。rs16969968的AA基因型的尼古丁依赖总体风险最高。然而,在rsl6969968位点具有AA基因型的个体中,同伴吸烟导致的尼古丁依赖差异比低风险基因型个体要低得多:AA = 2.5%,GA/AG = 11.2%,GG = 14.2%;P≤0.004。
在功能性SNP rs16969968(CHRNA5)位点具有高风险AA基因型的个体中,同伴吸烟对尼古丁依赖的影响比对低风险基因型个体的影响要小得多。这些结果凸显了这样一种可能性,即对于特定遗传风险个体,在有药物暴露的情况下,他们可能受社会环境的影响较小,并且针对社会因素的干预策略对遗传风险最高的个体影响可能较小。